Devenir des patients long terme aprs rsection trans-urthrale de la prostate

Key words : kidney ; renal angiomyoadenomatous tumor ; clear cell papillary renal cell carcinoma ; VHL gene ; renal cell carcinoma with leiomyomatous stroma ; relationship...

Au terme d’un suivi médian de 9,7 mois après l’arrêt, 98 % des patients étaient encore vivants, avec un bénéfice persis- tant du traitement pour la plupart d’entre eux : 91 %

sequence of ordinals an ordinal in such a way that for the 0-sequence its value is a, for a A;'-sequence s its value is P(<k, s(k)>), for a sequence whose domain is a

Optimization of Dosimetry in Alpha Therapy : Microlocalisation of 223Ra in Mouse Models of Metastasis from Prostate Cancer and Renal Cell Carcinoma.. Journal of Medical Imaging

A titre indicatif, comme pour le calcul propositionnel, la S5-satisfaisabilit´ e est dans la classe de complexit´ e P (probl` eme pouvant ˆ etre r´ esolu par une machine de Turing

Novel FH mutations in families with hereditary leiomyomatosis renal cell cancer (HLRCC) and in patients with isolated type 2 papillary renal cell carcinoma... Novel FH mutations

The negative association was particularly pronounced with a young age ( ≤ 40 years) at MetS onset (OR = 0.38 [0.16-0.89]), did not vary according to prostate cancer..

The aims of this study were (a) to quantify the use of ar- tificial nutrition near the end-of-life (during the 7 and 31 last days of life 15 ) for hospitalized cancer patients, and